Literature DB >> 3548858

Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase.

T L Kipnis, D V Tambourgi, M Sucupira, W Dias-da-Silva.   

Abstract

When T. cruzi trypomastigote forms are held at 45 degrees C for 10 min in saline they become susceptible to lysis by the alternative complement pathway. As the result of heating trypomastigotes, but not epimastigotes, substances are released into the fluid phase which inhibit EAC1,4,2,3 by inducing decay. The inhibition was most pronounced at the level of the decay of the C14b2a complex. C3 convertase of the classical pathway was also inhibited by live trypomastigote forms. These data suggest that the trypomastigote but not epimastigote forms of T. cruzi have cell surface modulators of C3 convertase that permit them to evade the lytic action of complement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3548858

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

Review 1.  Complement evasion by parasites: search for "Achilles' heel".

Authors:  Z Fishelson
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 2.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

3.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

4.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.

Authors:  M T Rimoldi; A Sher; S Heiny; A Lituchy; C H Hammer; K Joiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.

Authors:  E Fischer; M A Ouaissi; P Velge; J Cornette; M D Kazatchkine
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

7.  Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.

Authors:  K Iida; M B Whitlow; V Nussenzweig
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

Review 8.  The Complement System: A Prey of Trypanosoma cruzi.

Authors:  Kárita C F Lidani; Lorena Bavia; Altair R Ambrosio; Iara J de Messias-Reason
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

9.  Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi.

Authors:  T L Kipnis; D V Tambourgi; M J Alves; W D Silva
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.